TipRanks
Go Ultimate55% OFF

John Henderson Insider Profile

11 Followers

John Henderson, Director at Cytokinetics, holds 78.80K shares in Cytokinetics (Ticker: CYTK), holds 78.09K shares in Myriad Genetics (Ticker: MYGN).

John Henderson's Trading History

CYTK
Cytokinetics
Oct 20, 2026DirectorUninformative Buy22.50K$4.96M
MYGN
Myriad Genetics
Dec 06, 2019DirectorUninformative Buy―$495.87K

You May Also Like

John Henderson insider profile FAQ

What is the percentage of profitable transactions made by John Henderson?
The percentage of profitable transactions made by John Henderson is 67%.
What is the average return per transaction made by John Henderson?
The average return per transaction made by John Henderson is 9.90%.
What stocks does John Henderson hold?
John Henderson holds: CYTK, MYGN stocks.
What was John Henderson’s latest transaction?
John Henderson’s latest transaction was an Uninformative Buy of $22.50K.
What was John Henderson's most profitable transaction?
John Henderson’s most profitable transaction was an Informative Buy of CYTK stock on January 2, 2020. The return on the trade was 96.90%.
What is John Henderson's role in Cytokinetics?
John Henderson's role in Cytokinetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.